G. Evoniuk

1.4k total citations
37 papers, 1.0k citations indexed

About

G. Evoniuk is a scholar working on Psychiatry and Mental health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Evoniuk has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 11 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Evoniuk's work include Bipolar Disorder and Treatment (11 papers), Neuroscience and Neuropharmacology Research (8 papers) and Schizophrenia research and treatment (4 papers). G. Evoniuk is often cited by papers focused on Bipolar Disorder and Treatment (11 papers), Neuroscience and Neuropharmacology Research (8 papers) and Schizophrenia research and treatment (4 papers). G. Evoniuk collaborates with scholars based in United States, United Kingdom and Netherlands. G. Evoniuk's co-authors include S. M. Schanberg, C. Kühn, R. J. Wurtman, Reid W. von Borstel, Joseph DeVeaugh-Geiss, Cynthia M. Kuhn, Celeste A. Elash, Maryann Gnys, Chad Gwaltney and Joseph A. Johnston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

G. Evoniuk

37 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Evoniuk United States 17 300 239 227 217 138 37 1.0k
Christian Kissling Germany 14 205 0.7× 316 1.3× 233 1.0× 119 0.5× 68 0.5× 18 1.2k
Stefan Bleich Germany 25 319 1.1× 385 1.6× 216 1.0× 197 0.9× 138 1.0× 71 1.6k
Joseph Thavundayil Canada 21 166 0.6× 335 1.4× 385 1.7× 175 0.8× 73 0.5× 47 1.3k
Toshihito Suzuki Japan 27 416 1.4× 463 1.9× 438 1.9× 179 0.8× 204 1.5× 96 1.9k
Paul Ragan United States 12 277 0.9× 687 2.9× 152 0.7× 111 0.5× 107 0.8× 19 1.3k
Leighton Y. Huey United States 22 202 0.7× 316 1.3× 412 1.8× 112 0.5× 188 1.4× 54 1.3k
David R. Rubinow United States 20 228 0.8× 236 1.0× 222 1.0× 172 0.8× 136 1.0× 31 1.4k
Aryeh I. Herman United States 22 551 1.8× 384 1.6× 148 0.7× 361 1.7× 214 1.6× 35 1.4k
Norbert Wodarz Germany 22 272 0.9× 402 1.7× 232 1.0× 119 0.5× 133 1.0× 96 1.6k
Harvey C. Stancer Canada 22 203 0.7× 240 1.0× 475 2.1× 134 0.6× 150 1.1× 50 1.5k

Countries citing papers authored by G. Evoniuk

Since Specialization
Citations

This map shows the geographic impact of G. Evoniuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Evoniuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Evoniuk more than expected).

Fields of papers citing papers by G. Evoniuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Evoniuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Evoniuk. The network helps show where G. Evoniuk may publish in the future.

Co-authorship network of co-authors of G. Evoniuk

This figure shows the co-authorship network connecting the top 25 collaborators of G. Evoniuk. A scholar is included among the top collaborators of G. Evoniuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Evoniuk. G. Evoniuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ratti, Emiliangelo, P. Bettica, Robert Alexander, et al.. (2013). Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies. Journal of Psychopharmacology. 27(5). 424–434. 55 indexed citations
3.
Kemp, David E., Stephen J. Ganocy, Martin Brecher, et al.. (2010). Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. Journal of Affective Disorders. 130(1-2). 171–179. 44 indexed citations
4.
Bowden, Charles L., Suzanne Edwards, & G. Evoniuk. (2008). Open-Label, Concomitant Use of Lamotrigine and Other Medications for Bipolar Disorder. CNS Spectrums. 13(1). 75–83. 6 indexed citations
5.
Severus, W. Emanuel, Nikolaus Kleindienst, G. Evoniuk, et al.. (2008). Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study. Journal of Affective Disorders. 115(3). 466–470. 25 indexed citations
6.
Geddes, John, et al.. (2007). Lamotrigine for acute treatment of bipolar depression: individual patient data meta-analysis of 5 randomized, placebo-controlled trials. Bipolar Disorders. 9. 42–43. 3 indexed citations
7.
Weisler, Richard H., Joseph R. Calabrese, Charles L. Bowden, et al.. (2007). Discovery and development of lamotrigine for bipolar disorder: A story of serendipity, clinical observations, risk taking, and persistence. Journal of Affective Disorders. 108(1-2). 1–9. 36 indexed citations
8.
Geddes, John, et al.. (2006). Lamotrigine for acute treatment of bipolar depression: Additional clinical trial data and a retrospective pooled analysis of response rates across all randomized trials conducted by GSK. Bipolar Disorders. 8. 32–32. 4 indexed citations
9.
Shiffman, Saul, Joseph A. Johnston, Moise Khayrallah, et al.. (2000). The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology. 148(1). 33–40. 219 indexed citations
10.
11.
Evoniuk, G., et al.. (1991). A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice. Psychopharmacology. 105(1). 125–128. 22 indexed citations
12.
Evoniuk, G., et al.. (1991). The agonist pharmacophore of the benzodiazepine receptor. Synthesis of a selective anticonvulsant/anxiolytic. Journal of Medicinal Chemistry. 34(5). 1754–1756. 30 indexed citations
13.
Conlay, Lydia A., R. J. Wurtman, J. K. Blusztajn, et al.. (1989). Effects of running the Boston marathon on plasma concentrations of large neutral amino acids. Journal of Neural Transmission. 76(1). 65–71. 12 indexed citations
14.
Evoniuk, G. & Phil Skolnick. (1988). Anion Regulation of Agonist and Inverse Agonist Binding to Benzodiazepine Receptors. Journal of Neurochemistry. 51(4). 1169–1175. 4 indexed citations
15.
Conlay, Lydia A., G. Evoniuk, & R. J. Wurtman. (1988). Endogenous adenosine and hemorrhagic shock: effects of caffeine administration or caffeine withdrawal.. Proceedings of the National Academy of Sciences. 85(12). 4483–4485. 8 indexed citations
16.
Evoniuk, G., Reid W. von Borstel, & R. J. Wurtman. (1987). Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.. Journal of Pharmacology and Experimental Therapeutics. 240(2). 428–432. 64 indexed citations
17.
Evoniuk, G., Kenneth A. Jacobson, Mah T. Shamim, John W. Daly, & R. J. Wurtman. (1987). A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.. Journal of Pharmacology and Experimental Therapeutics. 242(3). 882–887. 33 indexed citations
18.
Borstel, Reid W. von, G. Evoniuk, & R. J. Wurtman. (1986). Adenosine potentiates sympathomimetic effects of nicotinic agonists in vivo.. Journal of Pharmacology and Experimental Therapeutics. 236(2). 344–349. 12 indexed citations
19.
McMillian, Michael, et al.. (1985). Ontogeny of food deprivation effects on ornithine decarboxylase: ornithine decarboxylase induction by alpha and beta agonists.. Journal of Pharmacology and Experimental Therapeutics. 235(2). 361–367. 2 indexed citations
20.
Evoniuk, G., Cynthia M. Kuhn, & Saul M. Schanberg. (1985). Hepatic cylic AMP generation and ornithine decarboxylase induction by glucagon and beta adrenergic agonists. Life Sciences. 36(21). 2075–2083. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Kissling Breakdown of academic impact, for papers by Stefan Bleich Breakdown of academic impact, for papers by Joseph Thavundayil Breakdown of academic impact, for papers by Toshihito Suzuki Breakdown of academic impact, for papers by Paul Ragan Breakdown of academic impact, for papers by Leighton Y. Huey Breakdown of academic impact, for papers by David R. Rubinow Breakdown of academic impact, for papers by Aryeh I. Herman Breakdown of academic impact, for papers by Norbert Wodarz Breakdown of academic impact, for papers by Harvey C. Stancer
Rankless by CCL
2026